Log in
Enquire now
Tyra Biosciences

Tyra Biosciences

Tyra Biosciences is a purpose-built cancer drugs.

OverviewStructured DataIssuesContributors

Contents

tyra.bio
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biology
Biology
0
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Technology
Technology
Biotechnology
Biotechnology
Location
San Diego
San Diego
Carlsbad, California
Carlsbad, California
0
Pitchbook URL
pitchbook.com/profiles...292432-42
Legal Name
Tyra Biosciences, Inc.0
Number of Employees (Ranges)
11 – 50
Email Address
info@tyra.bio0
Full Address
2656 State Street Carlsbad, CA 92008, USA0
CIK Number
1,863,1270
IRS Number
831,476,3480
Total Funding Amount (USD)
50,000,000
Latest Funding Round Date
January 13, 2020
Exchange
Nasdaq
Nasdaq
0
Board of Directors
Nina Kjellson
Nina Kjellson
0
‌
Robert More
0
‌
Isan Chen
0
‌
Jake Simson
0
‌
Melissa McCracken
0
‌
Sid Subramony
0
‌
Rehan Verjee
0
‌
Gilla Kaplan
0
CFO
‌
Esther van den Boom
0
Latest Funding Type
Series A
Series A
Patents Assigned (Count)
1
COO
‌
Daniel Bensen
0
Country
United States
United States

Other attributes

Company Operating Status
Active
SIC Code
2,8340
Ticker Symbol
TYRA0
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Tyra Biosciences

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.